APOL1 and Chronic Kidney Disease: New Findings in African Populations
Rasheed A. Gbadegesin, MD, MBBS
PeerDiagnosing IgAN: The Importance of Early and Accurate Identification
James Chevalier, MD
PeerInvestigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
John Sim, MD
PeerAchieving Optimal Outcomes in Lupus Nephritis: Key Updates from the 2024 ACR Guidelines
Robin Dore, MD
PeerIgAN Explained: Key Differences from Other Kidney Conditions
Mohamed Ibrahim, MB, BCh
PeerThe Pathogenesis of Complement 3 Glomerulopathy (C3G)
The Endothelin System and IgAN: Emerging Evidence
Donald Kohan, MD, PhD
PeerIgAN Insights: The Impact of Proteinuria
Laura H. Mariana, MD, MS,FASN
PeerThe Role of APRIL in IgA Nephropathy
Unraveling IgA Nephropathy Pathogenesis: APRIL and the Four-Hit Cascade
Unraveling IgA Nephropathy: Clinical Features and the Need for Early Diagnosis